Neuren Pharmaceuticals | NEU - Market Capitalization

Stock Price
12.30
Daily Change
0.27 2.24%
Monthly
5.31%
Yearly
32.40%
Q2 Forecast
11.77

Neuren Pharmaceuticals reported AUD1.58B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 5M 5M Sep/2025
Avita Medical AUD 105.47M 35.32M Dec/2025
Clinuvel Pharmaceuticals AUD 625.5M 105.22M Dec/2025
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Genetic Signatures AUD 56.78M 26.12M Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
Medical Developments International AUD 62.53M 563.29K Dec/2025
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Organon & Co USD 1.86B 916.43M Dec/2025
Paradigm Biopharmaceuticals AUD 145.7M 26.92M Dec/2025
PYC Therapeutics AUD 965.3M 209.97M Dec/2025
Tectonic Therapeutic USD 390M 96M Dec/2025
Telix Pharmaceuticals AUD 5.07B 5.81B Dec/2025
Viatris USD 14.34B 2.8B Dec/2025
Xeris Pharmaceuticals USD 1.3B 12M Dec/2025